Total submissions: 7
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| All of Us Research Program, |
RCV003454725 | SCV004823459 | likely benign | Malignant hyperthermia, susceptibility to, 5 | 2024-02-05 | criteria provided, single submitter | clinical testing | |
| Genome- |
RCV003456014 | SCV004179095 | benign | Hypokalemic periodic paralysis, type 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
| Genome- |
RCV003458360 | SCV004179094 | benign | Congenital myopathy 18 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
| Genome- |
RCV003454726 | SCV004179093 | benign | Thyrotoxic periodic paralysis, susceptibility to, 1 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
| Genome- |
RCV003454725 | SCV004179091 | benign | Malignant hyperthermia, susceptibility to, 5 | 2023-04-11 | criteria provided, single submitter | clinical testing | |
| Labcorp Genetics |
RCV000651236 | SCV000773087 | benign | Hypokalemic periodic paralysis, type 1; Malignant hyperthermia, susceptibility to, 5 | 2025-01-28 | criteria provided, single submitter | clinical testing | |
| Prevention |
RCV000243250 | SCV000301798 | likely benign | not specified | criteria provided, single submitter | clinical testing |